Search the Newsreel

Jefferies Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane has reiterated a Sell rating for Fresenius Medical Care AG & Co. KGaA (0H9X), setting a price target of €31.00. This follows similar Sell ratings from Bank of America Securities, while Citi maintained a Hold rating on July 17. The …

CRES6259535 Bond Profile — Key Metrics

This article provides a detailed profile of the CRES6259535 bond issued by IRSA Inversiones y Representaciones SA. Key metrics include an 8.00% coupon, a maturity date of March 31, 2035, and an outstanding amount of $180 million USD. The issuer, IRSA, is an Argentine …

Fresenius Medical Care: More Favorable Patient Outcomes Will Drive Growth (NYSE:FMS)

Deutsche Bank AG bescheinigt Hold für Fresenius Medical Care (FMC) St-Aktie

Fresenius Medical Care stock trades steady as dialysis group highlights margin recovery and stable c

The article discusses Fresenius Medical Care stock, focusing on the company's efforts to highlight margin recovery and stable cash flow in its dialysis business. It delves into revenue and earnings trends, margin comparisons, segment performance, balance sheet strength, and the impact of restructuring initiatives. …

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings Available within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care's FDA 510(k)-cleared software platform for kidney replacement therapy in the United States Aggregates existing therapy …

FMC stock trades steady as Fresenius Medical Care updates guidance and margin focus

Fresenius Medical Care (FMC) is focusing on improving profitability, with updated fiscal 2024 guidance projecting adjusted operating income growth of 5-15% despite revenue growth of only 0-3%. This strategic shift emphasizes operational efficiency, cost control, and margin expansion in its dialysis services and product …

IRSA stock trades steady as Argentina real estate group highlights portfolio value and recurring inc

IRSA, an Argentine real estate company, demonstrates steady stock performance driven by its focus on rental income and asset value. The company reported a consolidated adjusted EBITDA of approximately ARS 58.3 billion for fiscal 2023, with rental and services revenues exceeding ARS 60 billion, …

Avoiding Lag: Real-Time Signals in (IRS) Movement

This article provides a real-time signal analysis for Irsa Inversiones Y Representaciones S.a. (NYSE: IRS), highlighting neutral near and mid-term readings that could moderate a long-term positive bias. It details an exceptional risk-reward short setup and outlines three distinct AI-generated institutional trading strategies tailored …

Fresenius Medical Care stock trades around multi month low as restructuring and dividend follow weak 2023 earnings

Fresenius Medical Care's stock is trading near a multi-month low due to challenging 2023 earnings, which saw a significant decline in net income and a reduced dividend. The company's revenue increased slightly to over EUR 19 billion, driven by stable demand for dialysis services, …

Fresenius Medical Care stock stabilizes as cost measures support earnings outlook

Fresenius Medical Care's stock is stabilizing as the company's cost measures and restructuring efforts begin to support its earnings outlook. Despite past pressures from inflation and labor costs, the global leader in dialysis services is focusing on improving efficiency and optimizing its operations. Long-term …

FMC stock trades steadily as Fresenius Medical Care focuses on profitability and transformation

Fresenius Medical Care (FMC) is focusing on improving profitability and operational efficiency in its global dialysis business, which is reflected in the steady trading of its stock. Recent quarterly figures show enhanced efficiency, driven by cost-control programs and portfolio optimization, despite moderate revenue growth. …

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solesence, Inc. (SLSN) has introduced two new scalp care products, a Revitalizing Scalp Serum and a Scalp Screen Dry Shampoo SPF 45+ Sunscreen, utilizing its patented WHSPR and Kleair technologies. These launches aim to expand the company's consumer product portfolio and capitalize on the …

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan

J.P. Morgan analyst David Adlington has reiterated a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €37.40. This rating aligns with the overall analyst consensus of Moderate Sell for the company. Fresenius Medical Care AG & …

Fresenius Medical Care stock trades steady as turnaround efforts focus on margins and debt reduction

Fresenius Medical Care is undergoing a multi-year turnaround, with recent 2023 results showing rising revenue, improving margins, and targeted debt reduction. The company reported annual revenue of approximately EUR 19 billion and is focused on stabilizing operating profitability, evidenced by an adjusted operating result …

IRSA Inversiones (NYSE: IRS) plans July 23 interest payment on Series XXII notes

IRSA Inversiones y Representaciones Sociedad Anónima (NYSE: IRS) has announced that it will make an interest payment on its Fixed Rate Series XXII Notes, due in 2027, on July 23, 2026. This third installment, amounting to USD 450,511.02, covers the period from January 23, …

FMC stock trades steady as Fresenius Medical Care refines focus and margins

The article discusses how Fresenius Medical Care (FMC) stock performance is tied to the company's efforts in balancing dialysis growth, margin improvement, and capital discipline. It highlights revenue trends from global dialysis operations, profitability and margin comparisons, and the importance of balance sheet strength …

IRSA stock trades steady as Argentine real estate group navigates post-pandemic recovery

IRSA stock, representing a leading Argentine real estate group, is navigating post-pandemic recovery with recent annual results showing higher revenue and improving margins, particularly in its shopping mall and office segments. The company's performance reflects adaptation to high inflation and consumption shifts, with a …

Helikon Investments Ltd Acquires Additional Shares in IRSA Inver

Helikon Investments Ltd recently acquired an additional 477,516 shares in IRSA Inversiones y Representaciones SA at $15.44 per share, increasing its total holdings to 4,906,222 shares, which now constitutes 2.85% of Helikon's portfolio. This strategic move strengthens Helikon's position in Argentina's real estate sector, …

Previsão PLPL3 — Preço Alvo para 2027

Previsão MELK3 — Preço Alvo para 2027

IRSA Inversiones y Representaciones Sociedad Anónima 2026 Q3 - Results - Earnings Call Presentation

Plano&Plano (PLPL3): receita cresce +21, mas lucro cai -45%

Solesence (SLSN) Q1 2026 Earnings Transcript

Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)

IRSA Inversiones Y Representaciones Q3 Earnings Call Highlights

DAX Verlierer heute: Fresenius Medical Care unter Druck - Hannover Rück Aktie im Fokus

Earnings Call: Fresenius Medical Care übertrifft im 1. Quartal 2026 die Gewinnerwartungen, verfehlt aber die Umsatzprognose

Fresenius Medical Care-Aktie: Jetzt schon einsteigen?

Plano&Plano (PLPL3): Lucro líquido supera expectativas graças a melhores resultados financeiros

Plano & Plano (PLPL3) tem alta de 39% no lucro no 4º trimestre

Fresenius Medical Care Prognose: Aktie im Fokus – Chancen, Risiken und Kursziele 2026

FMC-Aktie knickt ein: Neues Dialysegerät dürfte Bilanz von Fresenius Medical Care 2026 belasten

Fresenius Medical Care-Aktie: Das war’s wohl!

Fresenius Medical Care steigert das operative Ergebnis 2025 um 27% und erreicht das obere Ende seiner Finanzprognose – die Marge liegt innerhalb der mittelfristigen Zielspanne für 2025

Jefferies & Company Inc. beurteilt Fresenius Medical Care (FMC) St-Aktie mit Underperform